IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Royalty Pharma Sub-Manager, LLC

Q1 2026 Holdings

Filed 2026-05-14 | 4 holdings | $172.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2026-08-21) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics, Inc(CYTK)COM23282W605$64.6M980,39237.4%
Zenas Biopharma, Inc.(ZBIO)ACOM98937L105$46.7M2,388,15027.0%
Zenas Biopharma, Inc.(BCAX)COM055477103$46.7M2,388,15027.0%
Biocryst Pharmaceuticals Inc(BCRX)COM09058V103$36.6M3,846,15421.2%
Biohaven LTD(BHVN)COMG1110E107$24.8M2,936,50714.4%